Cilicant

Pune, India Founded: 2011 • Age: 15 yrs Minicorn
Drugs for the biopharma sector are manufactured and supplied.

About Cilicant

Cilicant is a company based in Pune (India) founded in 2011 by Manish Jain. Cilicant has raised $2.04 million across 4 funding rounds from investors including o3 Capital, Flint Management and Manoj Ghiya. The company has 330 employees. Cilicant offers products and services including Desiccant Pouch, Oxygen Absorber Pouch, and Desiccant Canister. Cilicant operates in a competitive market with competitors including Ideal Cures, Legacy Pharma Solutions, Sanner, Eulysis and SCHOTT Poonawalla, among others.

Key Metrics
  • Annual Revenue
    ₹129 Cr

    FY 2024 · +36% YoY

  • Net Profit
    ₹10.13 Cr

    FY 2024 · 8% margin

  • EBITDA
    ₹26.57 Cr

    FY 2024 · 21% margin

  • Total Equity Funding
    $2.04M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.86M (USD), Seed

    Feb 2021

  • Investors
    o3 Capital

    & 8 more

  • Employee Count
    330

Products & Services of Cilicant

Cilicant offers a comprehensive portfolio of products and services, including Desiccant Pouch, Oxygen Absorber Pouch, and Desiccant Canister.

Desiccant Pouch
Packaging Material

Moisture-absorbing pouch for protecting pharmaceuticals and food products.

Oxygen Absorber Pouch
Packaging Material

Absorbs oxygen to extend shelf life of medical and food items.

Desiccant Canister
Packaging Material

Container for moisture control in various industrial applications.

Apps and channels of Cilicant

its YouTube channel CILICANT Active Packaging has 1.37K subscribers and 30 videos.

CILICANT Active Packaging
YouTube 1.37K subscribers 30 videos Howto & Style
Open channel

Videos from Cilicant

The most watched videos on Cilicant's YouTube channel, CILICANT Active Packaging (1.37K subscribers). Click a video to play it here.

CILICANT l Quality l Safety l Shelf life
1.5M views
Moisture Absorber for Stock! Safeguard your shop, store, warehouse with Freshcant Moisture Absorber
1.1M views
CILICANT wishes a very Happy Doctor's Day! #NationalDoctor’sDay2021
464.8K views
Preserve the freshness, flavour, & stability of packaged #FOOD products I Oxygen Absorber I CILICANT
336K views

More on CILICANT Active Packaging.

Funding Insights of Cilicant

Cilicant has successfully raised a total of $2.04M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.86 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.04M
  • Total Rounds 4
  • Last Round Seed — $1.86M
  • First Round $129,071

    (Mar 2015)

  • Investors Count 9

All 4 funding rounds of Cilicant with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2021$1.86MSeed$20.49Mo3 Capital
Feb 2019$12,352Seed$611,171–
–
Nov 2016$40,153Angel Round–Mohammad Husain Jamadar
Mar 2015$129,071Angel Round$•••••Manoj Ghiya
Valuation history
DateValuationStage
Feb 2021$20.49M••••••••

Last known valuation $20.49M (Feb 2021). 9 investors in total: 2 institutional and 7 angel.

Investors in Cilicant

Cilicant has secured backing from 9 investors, including institutional and angel investors. Prominent investors backing the company include o3 Capital, Flint Management and Manoj Ghiya.

All
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Provides software development services in JavaScript, SQL, and more.
2008flintmanagement.comHertfordshire, United Kingdom
Financial and strategic advice is offered by mid-market investment bank.
2007o3capital.comBengaluru, India

Manoj Ghiya

-
–unknown_31f4a8eb01ae4bfd9-

Rashmidevi Ghiya

-
–unknown_832551f1ac9d46cea-

Fahmim Hussain

-
–unknown_db5ead61f9ba4d86a-

Manish Jain

-
–unknown_46579aa72c8c425db-

Fahmim Hussain

-
–unknown_ee0b0b82b35c42929-

Rishika Manish Jain

-
–unknown_4af0b48d63e6430e9-

Mohammad Husain Jamadar

-
–unknown_258194d53e764f648-
Premium access

Investor details for Cilicant

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Cilicant Private Limited (Cilicant)

Cilicant Private Limited is the primary company behind Cilicant. The board of Cilicant Private Limited currently have 3 directors; the longest-serving is Rishika Manish Jain, appointed in 2011.

DirectorDesignationAppointedTenureEntity
Rishika Manish Jain
DIN 03355492
Whole-time director03 Mar 201115 yrs 7 moCilicant Private Limited
Manish Jain
DIN 03148460
Managing Director03 Mar 201115 yrs 7 moCilicant Private Limited
Shiraz Bugwadia Homi
DIN 01213884
Director22 Feb 20215 yrs 7 moCilicant Private Limited

People of Cilicant

7 people are tracked at Cilicant (5 in leadership, 2 in team); the tracked headcount is 330.

NameRoleGroup
Founder & Managing DirectorLeadership
Khushbu Patel Ravipati
Assistant General Manager - MarketingLeadership
Tamal Mukherjee
General Manager International MarketingLeadership
Sumeet Sharma
Director - SalesLeadership
Dr. Vivek Kumar Jha
Head Of Research And DevelopmentLeadership
Komal Bhavsar
Agm- Business Development (type Iii- Pharmaceutical Primary Packaging - Desiccants)Team
Tushar Mistry
Manager Of SalesTeam
Premium access

Complete people profiles for Cilicant

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Cilicant

Figures of Cilicant Private Limited, the primary company behind Cilicant, for FY 2024. Revenue was ₹129 Cr (+36% year on year). Net profit was ₹10.13 Cr (8% margin). EBITDA was ₹26.57 Cr (21% margin). Revenue has grown at a compounded annual rate of +31% over three years and +34% over five years.

  • ₹129 CrRevenue · FY 2024 · +36% YoY
  • ₹10.13 CrNet profit · 8% margin
  • ₹26.57 CrEBITDA · 21% margin
  • ₹0.74 CrPaid-up capital
  • 330Employees (provident fund records)
  • +31%Revenue CAGR, 3 years
  • +34%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Cilicant Private Limited are on its company page.

Premium access

Detailed financial statements for Cilicant

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Cilicant

4 dated milestones of Cilicant across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cilicant is founded.
  2. Funding First funding round of $129K.
  3. Funding Latest funding round, Seed, of $1.9M.
  4. Milestone Reaches Minicorn status.

Competitors of Cilicant

Cilicant operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ideal Cures, Legacy Pharma Solutions, Sanner, Eulysis and SCHOTT Poonawalla, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
idealcures.com1999Mumbai, India––
Manufacturer of pharmaceutical excipients and coatings systems for solid oral dosage forms
legacypackaging.com2003Earth, United States–331
Contract pharmaceutical packaging company
sanner-group.com1894Bensheim, Germany––
Plastic packaging solutions for pharmaceutical products are manufactured.
eulysis.com2010Cambridge, United States$4.8M–
Diabetes management and lifestyle modification services are provided.
schott-poonawalla.com1990Mumbai, India–1,297
Packaging solutions for pharmaceutical and biotech industries are provided.
naturalcapsules.com1993Bengaluru, India–99
Manufacturing and supply chain services for biopharma sector are provided.
nutra-med.com1999Hanover, United States––
Provider of drugs packaging services
ainia.com1987Paterna, Spain––
Pharmaceutical packaging services are provided by AINIA in Spain.
Premium access

Detailed competitors of Cilicant

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Cilicant

The website of Cilicant (cilicant.com) receives about 15.3K visits a month.

  • Monthly visits
    15.3K

    ▲ 148.2% vs previous month

Latest news on Cilicant

Premium access

Complete news archive for Cilicant

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Cilicant

10 companies that operate in the same segment as Cilicant (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cilicant

Cilicant was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Cilicant is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.

Cilicant is a funded company, having raised a total of $2.04M across 4 funding rounds to date. The company's 1st funding round was a Angel Round of $129.07K, raised on Mar 2015.

Cilicant has 330 employees.

The primary company behind Cilicant, Cilicant Private Limited, reported revenue of ₹129 Cr for FY 2024, up 36% year on year.

Cilicant was established in 2011 in Pune, India, as a manufacturer and supplier of drugs targeted at the biopharma sector. Operations involve production and distribution of pharmaceutical products to support biopharma applications. The company is directed by Founder and Managing Director Manish Jain, with a focus on reliable supply chains within the Indian pharmaceutical landscape. Core activities emphasize quality-controlled drug formulations for industry needs.

Cilicant's top competitors include Legacy Pharma Solutions, Natural Capsules and SCHOTT Poonawalla.

Cilicant offers Desiccant Pouch, Oxygen Absorber Pouch, and Desiccant Canister.

Cilicant has 9 investors. Key investors include o3 Capital, Flint Management, Manoj Ghiya, Rashmidevi Ghiya, and Fahmim Hussain.

The valuation of Cilicant is $20.49M as of Feb 2021.

Cilicant operates through Cilicant Private Limited.

The legal entities of Cilicant currently have 3 directors, including Shiraz Bugwadia Homi, Rishika Manish Jain, Manish Jain.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available